Integrated Cost Of Revenue vs Ebit Analysis

IDHC Stock

0.41 0.01 2.38%

Integrated Diagnostics financial indicator trend analysis is infinitely more than just investigating Integrated Diagnostics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Integrated Diagnostics is a good investment. Please check the relationship between Integrated Diagnostics Cost Of Revenue and its Ebit accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cost Of Revenue vs Ebit

Cost Of Revenue vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Integrated Diagnostics Cost Of Revenue account and Ebit. At this time, the significance of the direction appears to have strong relationship.

The correlation between Integrated Diagnostics' Cost Of Revenue and Ebit is 0.75. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebit in the same time period over historical financial statements of Integrated Diagnostics Holdings, assuming nothing else is changed. The correlation between historical values of Integrated Diagnostics' Cost Of Revenue and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Integrated Diagnostics Holdings are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Cost Of Revenue i.e., Integrated Diagnostics' Cost Of Revenue and Ebit go up and down completely randomly.

Correlation Coefficient

0.75

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Integrated Diagnostics income statement and represents the costs associated with goods and services Integrated Diagnostics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebit

Most indicators from Integrated Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Integrated Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to gain to about 339.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 168.1 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	2.8B	1.5B	1.5B	1.1B
Total Revenue	5.2B	3.6B	4.1B	2.3B

Gross Profit Total Revenue

Integrated Diagnostics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.51	0.92	0.96	0.85	0.88	0.13	0.92	0.98	0.82	0.95	0.48	0.82	0.84	0.46	0.57	-0.31	0.89	0.8	0.72	-0.42	0.99	0.84	0.96	0.73	-0.38
Short Long Term Debt Total	0.51		0.27	0.33	0.69	0.78	0.87	0.69	0.48	0.36	0.6	0.2	0.2	0.86	0.81	0.42	-0.87	0.74	0.81	0.69	-0.73	0.43	0.77	0.39	0.7	-0.43
Other Current Liab	0.92	0.27		0.97	0.66	0.74	-0.06	0.82	0.88	0.68	0.83	0.41	0.86	0.68	0.3	0.38	-0.16	0.77	0.65	0.59	-0.22	0.95	0.71	0.92	0.69	-0.24
Total Current Liabilities	0.96	0.33	0.97		0.76	0.77	-0.06	0.88	0.95	0.81	0.84	0.53	0.92	0.73	0.36	0.53	-0.18	0.79	0.68	0.58	-0.3	0.98	0.73	0.98	0.65	-0.39
Total Stockholder Equity	0.85	0.69	0.66	0.76		0.77	0.32	0.88	0.83	0.81	0.77	0.42	0.74	0.81	0.57	0.49	-0.49	0.76	0.76	0.71	-0.45	0.78	0.74	0.85	0.6	-0.31
Property Plant And Equipment Net	0.88	0.78	0.74	0.77	0.77		0.49	0.92	0.86	0.64	0.92	0.38	0.56	0.98	0.79	0.55	-0.67	0.99	0.96	0.88	-0.62	0.85	0.99	0.76	0.88	-0.48
Net Debt	0.13	0.87	-0.06	-0.06	0.32	0.49		0.31	0.08	-0.13	0.31	-0.01	-0.23	0.58	0.63	0.15	-0.79	0.43	0.54	0.47	-0.62	0.05	0.5	-0.03	0.55	-0.22
Retained Earnings	0.92	0.69	0.82	0.88	0.88	0.92	0.31		0.9	0.8	0.84	0.5	0.81	0.92	0.69	0.61	-0.6	0.92	0.9	0.75	-0.56	0.89	0.9	0.91	0.77	-0.53
Accounts Payable	0.98	0.48	0.88	0.95	0.83	0.86	0.08	0.9		0.84	0.92	0.6	0.81	0.82	0.46	0.67	-0.27	0.86	0.78	0.68	-0.45	0.98	0.82	0.95	0.68	-0.5
Cash	0.82	0.36	0.68	0.81	0.81	0.64	-0.13	0.8	0.84		0.67	0.44	0.85	0.64	0.39	0.6	-0.21	0.67	0.6	0.49	-0.3	0.8	0.61	0.88	0.38	-0.44
Non Current Assets Total	0.95	0.6	0.83	0.84	0.77	0.92	0.31	0.84	0.92	0.67		0.34	0.6	0.87	0.52	0.51	-0.38	0.92	0.85	0.81	-0.45	0.93	0.9	0.82	0.81	-0.31
Non Currrent Assets Other	0.48	0.2	0.41	0.53	0.42	0.38	-0.01	0.5	0.6	0.44	0.34		0.53	0.42	0.23	0.72	-0.05	0.34	0.31	0.13	-0.5	0.48	0.31	0.56	0.26	-0.77
Cash And Short Term Investments	0.82	0.2	0.86	0.92	0.74	0.56	-0.23	0.81	0.81	0.85	0.6	0.53		0.55	0.25	0.45	-0.1	0.59	0.5	0.38	-0.19	0.83	0.53	0.94	0.41	-0.35
Net Receivables	0.84	0.86	0.68	0.73	0.81	0.98	0.58	0.92	0.82	0.64	0.87	0.42	0.55		0.82	0.58	-0.73	0.97	0.96	0.85	-0.68	0.8	0.97	0.74	0.88	-0.53
Good Will	0.46	0.81	0.3	0.36	0.57	0.79	0.63	0.69	0.46	0.39	0.52	0.23	0.25	0.82		0.33	-0.9	0.77	0.83	0.8	-0.6	0.41	0.81	0.37	0.69	-0.44
Common Stock Total Equity	0.57	0.42	0.38	0.53	0.49	0.55	0.15	0.61	0.67	0.6	0.51	0.72	0.45	0.58	0.33		-0.18	0.51	0.47	0.2	-0.46	0.56	0.48	0.56	0.34	-0.88
Common Stock Shares Outstanding	-0.31	-0.87	-0.16	-0.18	-0.49	-0.67	-0.79	-0.6	-0.27	-0.21	-0.38	-0.05	-0.1	-0.73	-0.9	-0.18		-0.65	-0.79	-0.7	0.68	-0.24	-0.72	-0.23	-0.64	0.33
Non Current Liabilities Total	0.89	0.74	0.77	0.79	0.76	0.99	0.43	0.92	0.86	0.67	0.92	0.34	0.59	0.97	0.77	0.51	-0.65		0.96	0.89	-0.59	0.87	0.99	0.78	0.87	-0.44
Inventory	0.8	0.81	0.65	0.68	0.76	0.96	0.54	0.9	0.78	0.6	0.85	0.31	0.5	0.96	0.83	0.47	-0.79	0.96		0.91	-0.69	0.76	0.99	0.7	0.86	-0.44
Other Current Assets	0.72	0.69	0.59	0.58	0.71	0.88	0.47	0.75	0.68	0.49	0.81	0.13	0.38	0.85	0.8	0.2	-0.7	0.89	0.91		-0.46	0.68	0.91	0.58	0.83	-0.11
Other Stockholder Equity	-0.42	-0.73	-0.22	-0.3	-0.45	-0.62	-0.62	-0.56	-0.45	-0.3	-0.45	-0.5	-0.19	-0.68	-0.6	-0.46	0.68	-0.59	-0.69	-0.46		-0.37	-0.64	-0.35	-0.54	0.67
Total Liab	0.99	0.43	0.95	0.98	0.78	0.85	0.05	0.89	0.98	0.8	0.93	0.48	0.83	0.8	0.41	0.56	-0.24	0.87	0.76	0.68	-0.37		0.82	0.95	0.72	-0.38
Property Plant And Equipment Gross	0.84	0.77	0.71	0.73	0.74	0.99	0.5	0.9	0.82	0.61	0.9	0.31	0.53	0.97	0.81	0.48	-0.72	0.99	0.99	0.91	-0.64	0.82		0.72	0.88	-0.43
Total Current Assets	0.96	0.39	0.92	0.98	0.85	0.76	-0.03	0.91	0.95	0.88	0.82	0.56	0.94	0.74	0.37	0.56	-0.23	0.78	0.7	0.58	-0.35	0.95	0.72		0.6	-0.41
Short Term Debt	0.73	0.7	0.69	0.65	0.6	0.88	0.55	0.77	0.68	0.38	0.81	0.26	0.41	0.88	0.69	0.34	-0.64	0.87	0.86	0.83	-0.54	0.72	0.88	0.6		-0.29
Intangible Assets	-0.38	-0.43	-0.24	-0.39	-0.31	-0.48	-0.22	-0.53	-0.5	-0.44	-0.31	-0.77	-0.35	-0.53	-0.44	-0.88	0.33	-0.44	-0.44	-0.11	0.67	-0.38	-0.43	-0.41	-0.29

Click cells to compare fundamentals

Integrated Diagnostics Account Relationship Matchups

Integrated Diagnostics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.8B	4.2B	6.2B	5.3B	5.8B	4.1B
Short Long Term Debt Total	444.8M	552.1M	98.1M	116.4M	1.2B	1.2B
Other Current Liab	374.0M	488.3M	1.4B	871.0M	679.8M	412.0M
Total Current Liabilities	828.2M	1.0B	2.3B	1.5B	1.3B	880.3M
Total Stockholder Equity	2.2B	2.3B	2.6B	2.2B	2.7B	2.4B
Property Plant And Equipment Net	1.1B	1.1B	1.5B	1.9B	2.1B	2.2B
Net Debt	35.9M	(48.1M)	(793.4M)	(532.1M)	504.9M	530.2M
Retained Earnings	456.7M	603.3M	1.6B	783.1M	1.3B	1.3B
Accounts Payable	145.2M	177.6M	311.3M	269.8M	271.7M	165.7M
Cash	408.9M	600.1M	891.5M	648.5M	674.3M	572.3M
Non Current Assets Total	2.7B	2.8B	3.2B	3.7B	3.8B	2.8B
Non Currrent Assets Other	(1K)	276.6M	1.5B	18.1M	20.8M	19.7M
Cash And Short Term Investments	630.5M	876.8M	2.4B	815.9M	860.5M	815.7M
Net Receivables	261.7M	326.8M	373.9M	397.5M	571.5M	600.1M
Good Will	1.3B	1.3B	1.3B	1.3B	1.3B	1.4B
Liabilities And Stockholders Equity	3.8B	4.2B	6.2B	5.3B	5.8B	4.1B
Non Current Liabilities Total	567.0M	741.7M	1.1B	1.4B	1.4B	1.5B
Inventory	84.3M	100.1M	222.6M	265.5M	374.7M	393.4M
Other Current Assets	61.4M	56.7M	95.9M	146.4M	155.7M	163.5M
Other Stockholder Equity	1.1B	1.1B	1.1B	1.1B	(427.1M)	(405.8M)
Total Liab	1.4B	1.8B	3.4B	2.8B	2.7B	1.5B
Property Plant And Equipment Gross	1.1B	1.1B	2.1B	2.8B	3.2B	3.4B
Total Current Assets	1.0B	1.4B	3.0B	1.6B	2.0B	1.3B
Accumulated Other Comprehensive Income	(387.7M)	(482.7M)	(1.1B)	(780.8M)	(753.2M)	(715.6M)
Short Term Debt	87.1M	85.9M	137.2M	171.4M	220.4M	231.4M
Intangible Assets	398.6M	399.8M	402.5M	418.2M	422.9M	335.8M
Other Liab	196.8M	209.3M	275.5M	371.3M	427.0M	222.5M
Net Tangible Assets	597.6M	554.7M	610.2M	924.0M	1.1B	551.2M
Long Term Debt	81.3M	67.6M	76.3M	93.8M	67.5M	58.8M
Property Plant Equipment	705.8M	1.0B	1.1B	1.5B	1.7B	1.8B
Short Term Investments	221.6M	276.6M	1.5B	167.4M	186.3M	365.1M
Capital Lease Obligations	338.1M	459.0M	760.7M	1.1B	1.1B	556.7M
Net Invested Capital	2.3B	2.4B	2.7B	2.3B	2.8B	2.7B
Net Working Capital	209.7M	351.0M	693.6M	160.2M	686.9M	468.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Integrated Cost Of Revenue vs Ebit Analysis

Cost Of Revenue vs Ebit

Cost Of Revenue vs Ebit Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Ebit

Integrated Diagnostics fundamental ratios Correlations

Integrated Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Integrated Diagnostics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Integrated Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.99	Inventory
Accounts Payable	+ 0.98	Total Assets

Common Stock Shares Outstanding	- 0.9	Good Will
Intangible Assets	- 0.88	Common Stock Total Equity
Common Stock Shares Outstanding	- 0.87	Short Long Term Debt Total
Inventory	- 0.79	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.79	Net Debt
Intangible Assets	- 0.77	Non Currrent Assets Other